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Introduction
The normal umbilical cord (UC) growth is an essential
prerequisite for dynamic fetal development during
pregnancy. Regular exchange of nutritional sub-
stances, respiratory gases and biologically active fac-
tors by the umbilical and placental vessels protect the
fetus from intrauterine growth retardation and death.
UC in several species contains two arteries, one vein
and the allantoic duct, which are surrounded by spe-
cific embryonic tissue named Wharton's jelly. The
whole UC is covered by the amniotic epithelium,
which undergoes structural reorganization from single
layer at the beginning to a multilayered structure at
term [1]. Blood circulated in UC vessels do not only
provide transport for nutritional substances and respi-
ratory gases but also is an important source of stem
cells which can be used to treat hematopoietic and
genetic disorders [2]. The major limitation to a wider
use of this source of stem cells is their relative low
number after isolation from single unit of cord blood
[3]. Collagen, elastin, hyaluronic acid and several sul-
phated proteolgycans are major extracellular compo-
nents of Wharton's jelly, which contains low number
of cells [4,5]. High amounts of these compounds in the
Wharton's jelly have been suggested to be responsible
for resistance after stretching or compression evoked
by fetal movements and uterine contraction [1,6,7].
Formation of UC structures during early stage of preg-
nancy and their growth are correlated with size of the
fetus [1,8]. Structural dysfunction related especially
with the umbilical vessels and Wharton's jelly may
result in a decrease in efficiency of the umbilical and
placental circulation, which can affect fetus intra-uter-
ine mortality and post-partum survival of piglets. Fur-
thermore, intrapartum stillbirth accounts for 20% of all
prenatal mortality in pigs and it is predominantly 
a result of fetal asphyxiation associated with prema-
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Abstract: The fibroblast growth factors (FGFs) are multifunctional proteins that, among other roles, regulate structural reor-
ganization of uterine and placental vascular bed during pregnancy. Thus, we analyzed mRNA and protein expression and
immunohistochemical localization of FGF-1 and FGF-2, and their receptors (FGFR-1 and FGFR-2) in the developing
umbilical cord (UC) on days 40, 60, 75 and 90 of pregnancy and after the physiological delivery in the pig (day 114). qPCR
analysis demonstrated an increase in FGF-1 and FGF-2 mRNA levels beginning on day 75 and on day 114 of pregnancy,
respectively. In addition, significantly increased FGFR-1IIIc mRNA expression was also found on day 114. On the other
hand, no significant changes in FGFR-2IIIb mRNA expression were observed. Western Blot analysis revealed a decrease in
FGF-1 and FGFR-2 protein expression after day 40. Beside an increased protein expression of FGF-2 on day 60, no signif-
icant changes in FGFR-1 protein expression were detected. Immunohistochemical staining enabled detection of FGF-FGFR
system, with different intensity of immunoreaction in endothelial and tunica media cells of the umbilical vessels and in
allantoic duct and amniotic epithelium as well as in myofibroblasts. In conclusion, our results show that members of FGF-
FGFR system are expressed specifically in UC structures. Furthermore their day of pregnancy-related expression suggest
that they may be an important players during UC formation and development.
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ture rupture of the UC [9-11]. Higher frequency of
piglet asphyxiation is usually the consequence of UCs
that are too short and too thin in comparison to the dis-
tance from the ovarian end of the uterine horn to the
vulva, and fetus weight [8].
Mechanisms controlling UC development are still
poorly known. However, formation and dynamic
growth of UC seem to be controlled by the locally pro-
duced growth factors, among others, numerous and
still expanding fibroblast growth factor (FGF) family
and their receptors. FGFs represent multifunctional
heparan-like glycosaminoglycans-binding mitogens
that stimulate migration, differentiation and prolifera-
tion of cells of mesenchymal and neuroectodermal ori-
gin [12,13]. Among the 22 different FGFs family
members, FGF-1 and FGF-2 with molecular weight of
18-24 kDa, are well characterized. The mitogenic and
angiogenic effect of FGFs observed in target cells is
the result of their interactions with receptors of four
major known transmembrane tyrosine kinase receptors
– FGFR1-4 [14,15]. Alternative splicing resulting in
the formation of IIIb or IIIc isoforms of FGFR-1, -2
and -3 specifies the sequence of the Ig domain III
[16,17]. The two alternative forms display different
ligand-binding characteristic. It has been shown that
FGFR-1IIIc isoform is expressed in cells of mes-
enchymal orgin (vascular endothelium), while FGFR-
2IIIb is exclusively expressed in epithelial cells [18].
Participation of FGF-FGFR system in UC forma-
tion and development is possible given its stimulatory
influence especially on placental vascular adaptation
during pregnancy [19,20]. Furthermore, FGF-1 and
FGF-2 probably regulate production of large amounts of
collagen and glycosaminoglycans by miofibroblasts
what affects on UC elasticity and degree of hydration
[21,22]. Therefore, in the present study we have com-
pared mRNA and protein expression levels of FGF-1
and FGF-2 as well as two respective receptors FGFR-
1IIIc and FGFR-2IIIb and their immunohistochemical
localization, in the porcine UCs on days 40, 60, 75, and
90 of pregnancy and on the day of parturition (day 114). 
Materials and methods 
The porcine umbilical cords. The UCs were obtained from 60
piglets (parents: Large White x Polish Landrace) classified into five
groups according to gestation age: days 40 (n=12), 60 (n=12), 75
(n=12), 90 (n=12) of pregnancy and one postnatal group – 114, arbi-
trary day of pregnancy (n=12). The UCs from gilts in 40, 60, 75 and
90 day of pregnancy were obtained just after slaughter at a local
slaughterhouse. However, the UCs from animals classified into post-
natal group were collected directly from piglets during natural par-
turition. The gilts from this group were continuously monitored until
the end of pregnancy. Additionally, the UCs from animals on days
60, 75, 90 of pregnancy and from postnatal group were divided into
three parts: periplacental, middle and perifetal. The selected frag-
ments of UCs for Western Blot and qPCR analyses were snap
frozen in liquid nitrogen, before storage at -80°C. For immunohis-
tochemical staining, the tissues were fixed in 4% paraformaldehyde
in 0.1M phosphate buffer (PB, pH 7.4) for 4 h at 4°C, washed in 0.1M
PB and stored in 30% sucrose for cryoprotection.
All animals were housed and used according to the animal care
guidelines. All experimental procedures had been previously submit-
ted to and approved by the Local Research Committee and conduct-
ed according to the national guidelines for agricultural animal care.
Total RNA isolation and reverse transcription. The frozen UCs
placed in Lysing Matrix D tubs (MP Biomedicals Inc. Solon, OH,
USA) with Fenozol (A&A Biotechnology, Gdañsk, Poland) were
mechanically homogenized in FastPrep®-24 homogenizer (MP
Biomedicals Inc. Solon, OH, USA). Next, total RNA was extract-
ed from tissues homogenates by Total RNA Kit (A&A Biotechnol-
ogy, Gdañsk, Poland) according to the manufacturer's protocol.
The quality of total RNA was determined by both the ratio of
A260/A280 and RNA gel electrophoresis.
Before the reverse transcription reaction, constant amount of
1μg of total RNA were treated with DNase I (Sigma Aldrich,
Munich, Germany). The reverse transcription reaction was per-
formed with using Reverse Transcription System kit (Promega,
Madison, WI, USA) according to the manufacturer's protocol.
qPCR. Primers for qPCR were designed by Primer 3 software
(http://frodo.wi.mit.edu/; FGF-1, FGF-2) and Primer Express 2.0
(Applied Biosystems, Foster City, CA, USA; FGFR-IIIc, FGFR-
2IIIb) using cDNA sequences from Gene-Bank. Primers for β-actin
were used according to the literature [23]. Forward and reverse
primer sequences used to amplify mRNA for FGF-1, FGF-2,
FGFR-1IIIc, FGFR-2IIIb and β-actin genes and expected product
size were placed in Table 1. All qPCR analysis was performed
with a ABI Prism 7300 sequence detection system using SYBR
Green PCR master mix (Applied Biosystems). Serial dilutions of
the appropriate cDNA were used as standard curves for gene
quantification. The cycling conditions were as follows: initial
denaturation 95°C for 10 min, followed by 40 amplification
cycles at denaturation in 95°C for 15 s, annealing 59°C (for
FGFR-1IIIc) and 60°C at 45 s (for FGF-1, FGF-2, FGFR-2IIIb
and β-actin) followed by extension at 72°C for 45 s. After each
PCR reaction, melting curves were obtained by stepwise increas-
es in the temperature from 60 to 95°C to ensure single product
amplification. The specificity of RT-PCR products was con-
firmed by gel electrophoresis and sequencing. Expression level
for investigated factors was normalized to the expression of
housekeeping gene β-actin to obtain arbitrary units of relative
amount of the PCR product.
Western Blot. The cytosol and membrane fractions for Western
Blot analysis were obtained from 60 UC segments (twelve per
group). Tissue were placed in the homogenization buffer (50mM
Tris-HCl, pH 7.4; 10mM EDTA, 150mM NaCl, 1% Triton X-
100, 1μM pepstatin A, 5μg/ml leupeptin, 5μg/ml aprotinin,
100mM PMSF) and mechanically homogenized on ice.
Homogenates were centrifuged at 2500 x g for 10 min at 4°C and
the collected supernatant was centrifuged additionally at 105 000
× g for 1 h at 8°C in order to separate cytosol and membrane frac-
tions, which were kept frozen at -80°C to future analyses. The
protein level was spectrophotometrically determined by Brad-
ford's method [24]. An equal amount (30μg) of cytosol (FGF-1,
FGF-2, β-actin); and membrane (FGFR-1, FGFR-2) fractions
were separated using SDS-PAGE gel and transferred onto a
0.2μm nitrocellulose membrane (Sigma Aldrich). After transfer,
non-specific protein binding was blocked by incubation of 
nitrocellulose membranes with 5% non-fat dry milk in TBS-T
buffer (50 mM Tris-HCl, pH 7.4; 150 mM NaCl, 0.1% Tween-20)
for 1 h at room temperature. The membranes were then incubated
with rabbit polyclonal antibody raised against FGF-1 (sc-7910;
1:400), FGF-2 (sc-79; 1:400), FGFR-1 (sc-121; 1:350), FGFR-2 (sc
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-122; 1:350) or β-actin (sc-47778; 1:1500) used as a reference pro-
tein (Santa Cruz Biotechnology, Santa Cruz, CA, USA), in TBS-T
buffer overnight at 4°C. After several washings with TBS-T the
membranes were incubated for 1 h with goat anti-rabbit IgG biotin-
labeled antibody in dilution 1/700 (FGF-1, FGF-2), 1/600 (FGFR-
1, FGFR-2) and 1/3000 (β-actin), (Vector Laboratories Inc.
Burlingame, CA, USA). Additionally, to test the specificity of the
FGF-2 and FGFR-1 and FGFR-2 antisera, primary antibodies (1
μg) were incubated with specific blocking peptides (6 μg) (Santa
Cruz Biotechnology) in TBS-T buffer for 2 h at room temperature
with gentle shaking. Immunoreactive bands were detected using the
avidin-biotin-peroxidase method (ABC Reagent, Vectastain® Kit,
Vector Laboratories Inc.) in combination with 3,3'-diaminobenzi-
dine (Sigma Aldrich). The intensity of the Western Blot bands were
analysed with the Kodak 1D software v. 3.5 visual quantitative sys-
tem (Eastman Kodak, Rochester, NY, USA). 
Immunohistochemistry. Cryostat sections (10 μm) from differ-
ent parts of UC (periplacental, middle and perifetal) were mount-
ed on chromogelatin-precoated Superfrost plus® slides (Menzel-
Galaser, Braunschweig, Germany). Endogenous peroxidase
activity was blocked by incubating tissue sections in methanol
with 3% H2O2 for 30 min at room temperature. Then tissue sec-
tions were incubated with 10% normal goat serum for 1 h at room
temperature (NGS, Vector Laboratories Inc.) to reduce non-spe-
cific background staining. Afterwards, they were incubated
overnight at room temperature with the same antibodies used for
Western Blot diluted as follows: 1/200 FGF-1, FGF-2 and 1/150
Fig. 1. qPCR analysis of mRNA FGF-1 (a), FGF-2 (b), FGFR-1IIIc (c) and FGFR-2IIIb (d) expression in porcine umbilical cord on days
40, 60, 75, 90 and 114 of pregnancy. Data are presented as mean ± SEM relative to b-actin gene expression (n=12). Different small let-
ters indicate significant differences (P < 0.05). (e) Representative photography of the agarose electrophoresis gel of the qPCR amplifica-
tion products for: line M – molecular mass standard, line 1 – FGF-1 (209 bp), line 2 – FGF-2 (219 bp), line 3 – FGFR-1IIIc (52 bp), line
4 – FGFR-2IIIb (54 bp) resolved by 2% agarose gel.
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Table 1. Summary of qPCR primers sequences, products size and GeneBank Accession Numbers and/or references for investigated fac-
tors and receptors. 
575FGF-FGFR in the porcine umbilical cord
©Polish Histochemical et Cytochemical Society
Folia Histochem Cytobiol. 2010:48(4): 575 (572-580) 
Doi: 10.2478/v10042-010-0073-4
FGFR-1, FGFR-2. Primary antibodies of FGFs and FGFRs were
detected with goat anti-rabbit IgG biotin conjugate secondary
antibody (Vector Laboratories Inc.) in dilution 1/500 for FGF and
1/400 for FGFR for 1 h at room temperature. Next, sections were
rinsed in phosphate buffer saline (PBS) and incubated in strepa-
vidin-biotin-peroxidase complex solution (ABC Reagent, Vectas-
tain® Kit, Vector Laboratories Inc.). The reaction product was
visualized using 3,3-diaminobenzidine (DAB, Sigma Aldrich).
Two types of controls were performed to determine the specifici-
ty of immunohistochemical staining: (1) the primary antibody
was omitted during the immunostainig procedure; (2) the primary
antibody was substituted with nonspecific IgG. The sections were
cover-slipped with DPX mounting medium (Park Scientific Ltd.,
Northampton, UK). Twelve sections from each group which con-
tained all analyzed structures (umbilical vein, arteries, amniotic
epithelium, allantoic duct and Wharton's jelly) were selected.
Finally, the sections were photographed and visible color prod-
ucts of FGF-1, FGF-2, FGFR-1, and FGFR-2 immunoreactions
were examined according to the standard 4 point scale for inten-
sity: (-) negative, (+) week reaction, (++) strong reaction and
(+++) very strong reaction [25].
Statistical analysis. The Real Time PCR and Western Blot numer-
ical data are expressed as mean ±SEM. Significant differences
were analyzed using one-way ANOVA followed by the Bonferroni
multiple-comparison test (GraphPad PRISM v.4.0, GraphPad Soft-
ware, Inc., San Diego, CA). The differences were considered to be
significant at p<0.05.
Results
mRNA expression of FGF-1, FGF-2, 
FGFR-1IIIc and FGFR-2IIIb
Preliminary analysis of mRNA expression of exam-
ined members of FGF-FGFR system did not show sig-
nificant differences between periplacental, middle and
perifetal parts of UCs. Therefore, numerical data
obtained from mentioned fragments of UCs were ana-
lyzed together. Gel electrophoresis of the qPCR ampli-
fication products demonstrated single transcripts for
the two isoforms of FGF (FGF-1 – 209 bp, FGF-2 –
219 bp) and FGF receptors (FGFR-1IIIc – 52 bp,
FGFR-2IIIb – 54 bp) (Fig. 1e). FGF-1 mRNA
increased (p<0.01) from days 40 and 60 to day 75 of
pregnancy, but did not change between days 75, 90 and
114 of pregnancy (Fig. 1a) whereas the abundance of
Fig. 2. (a-d) Western Blot analysis of
FGF-1 (a), FGF-2 (b), FGFR-1 (c)
and FGFR-2 (d) in the porcine umbil-
ical cord on days 40, 60, 75, 90 and
114 of pregnancy. Upper panels: repre-
sentative blots of tissue homogenates
(30 µg) resolved by 15% (FGF-1,
FGF-2) and 10% (FGFR-1), and 6%
(FGFR-2) SDS-PAGE and immuno-
blotted with FGF, FGFR and β-actin
as a reference protein antibody.
Lower panels: results of densitomet-
ric quantification of bands (KODAK
ID v. 3.5; Eastman). All values are
the mean ± SEM of the protein level
in the UC (n=12). Protein expression
level for investigated factors and
receptors were normalized to the ref-
erence protein β-actin. Different
small letters indicate significant dif-
ferences (P < 0.05). (e-g) Western
blot analysis of FGF-2 (e), FGFR-1
(f) and FGFR-2 (g) antibody speci-
ficity in the umbilical cord tissue
homogenates (30 µg) form day 75
and 90 of pregnancy in absence (non-
blocked) or presence of blocking
peptides (blocked). NSB – nonspecif-
ic binding.
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FGF-2 mRNA was greatest (p<0.05) on days 60 and
114 of pregnancy (Fig. 1b). FGFR-1IIIc mRNA in UC
was most abundance on day 114 (p<0.01; Fig. 1c)
whereas there was no effect of day of pregnancy on val-
ues for FGFR-2IIIb (Fig. 1d).
Protein expression of FGF-1, FGF-2, FGFR-1
and FGFR-2
Protein expression of FGF-FGFR system members,
similarly to mRNA expression did not show significant
differences between periplacental, middle and perifetal
parts of UCs. Numerical data obtained from mentioned
above fragments of UCs were pooled and analyzed
together. The FGF-1 protein was detected at approxi-
mately 20 kDa (Fig. 2a). The greatest expression of
FGF-1 was on day 40 (p<0.001; 40 vs. 90; p<0.01; 
40 vs. 60, 75 and 114). Furthermore, a decrease in FGF-
1 protein was detected on day 90 as compared to days
60 and 75 of pregnancy (p<0.01). The antibody to FGF-
2 detected a protein at approximately 19 kDa (Fig. 2e).
Expression of FGF-2 increased only on day 60 as com-
pared to day 75 of pregnancy (p<0.05) (Fig. 2b). The
antibody FGFR-1 recognized a protein of 90 kDa as
expected (Fig. 2f), but expression of this protein was no
affected by day of pregnancy (Fig. 2c). The antibody to
FGFR-2 detected a protein of 120 kDa, as expected
(Fig. 2g) and this protein was most abundant on day 40
of pregnancy (p<0.001), but was also more abundant on
day 75 and 90 than on days 60 and 114 (Fig. 2d).
Immunohistochemical localization of FGF-1,
FGF-2, FGFR-1 and FGFR-2
Tissue sections of UCs stained for FGF-1 (Fig. 3a-h),
FGF-2 (Fig. 3i-p) along with FGFR-1 (Fig. 4a-h) and
FGFR-2 (Fig. 4i-p) demonstrated positive reaction in
the endothelium and tunica media of the UC vein (Fig.
3/4a,e,i,m) and artery (Fig. 3/4b,f,j,n) in the amniotic
epithelium (Fig. 3/4c,g,k,o) and allantoic duct (Fig.
3/4d,h,l,p), and in myofibroblasts of Wharton's jelly
(Fig. 3/4c,g,k,o). No staining for studied factors and
receptors was observed in negative control slides (data
not shown).
Strong intensity of immunohistochemical reaction
for FGF-1 was detected in the endothelium of umbili-
cal vein and arteries, and in the amniotic epithelium,
and allantoic duct (Table 2). On the other side, weaker
but still strong reaction for FGF-1 was observed in tuni-
ca media of umbilical vessels and in myofibriblasts of
Wharton's jelly. Immunoreactivity of the FGF-2 was
very strong in all the analyzed structures for all the days
of pregnancy observed (Table 2). Similar to the FGF-1,
FGFR-1 immunoreaction was more intensive in the
endothelium of vein and arteries as well as in amniotic
epithelium and allantoic duct when compared with the
tunica media of the umbilical vessels (Table 2). As for
FGFR-2, the highest intensity of immunoreaction was
observed in endothelium of umbilical vessels, in the
amniotic epithelium, allantoic duct and in myofibrob-
lasts of Wharton's jelly, too. Immunoreactivity for
FGFR-2 in tunica media of vein and arteries was weak-
er in comparison with the above mentioned structures
(Table 2).
Discussion
Results of this study are the first to describe changes in
expression of FGF-1, FGF-2, FGFR-1IIIc and FGFR-
2IIIb with respect to cellular localization of mRNAs
and proteins in tissues of the UC of the pigs during
pregnancy and on the day of parturition. Earlier
reports indicated expression of FGFs and FGFRs in
various cells of human and ovine placenta
[19,20,26,27] which suggest that they may act as
important regulators of UC function, especially func-
tions related to blood circulation in the UC. High
level of FGF-1 and FGFR-1 protein expression on
day 40 of pregnancy and modest increase in expres-
Table 2. Schematic presentation of FGF-1, FGF-2, FGFR-1 and
FGFR-2 immunoreactivity changes on day 40, 60, 75, 90 and 114
of pregnancy in structures of porcine umbilical cord. Immunos-
taining score: (-) negative, (+) weak reaction, (++) strong reaction,
(+++) very strong reaction. 
VE – venous endothelium, AE – arterial endothelium, TMUV – tunica
media of umbilical vein, TMUA – tunica media of umbilical artery, AE –
amniotic epithelium, ADE – allantoic duct epithelium, M – myofibroblasts.
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sion of FGF2 suggest that they play important role in
UC formation. On the other hand, higher expression
of FGF-1, FGF-2 and FGFRIIIc on mRNA level
within second half of pregnancy or only on day 114
suggests that we should also observe increase of pro-
tein expression for these factors and receptor. Given
standard models wherein protein level should be cor-
relate with mRNA expression the discrepancy
between mRNA and protein expression occurring in
our study disturbs the results. However, protein and
RNA represent different steps of the multi-stepped
cellular genetic information flow process, in witch
they are dynamically produced and degraded. Wang
[28] based partially on results of Le Roch et al. [29],
Griffin et al. [30] and Tian et al. [31] described four
scenarios of differential changes in mRNA and pro-
tein levels: steady RNA, lower protein; steady RNA,
higher protein; lower RNA, steady protein; higher
RNA, steady protein. Based on these findings and
given that there is no similar study, the discrepancy
between protein and mRNA abundance which we
have observed is most likely a result of the biology of
gene expression rather than the measurement errors.
Because posttranscriptional, translational, or post-
translational regulations are not well understood fur-
ther studies are needed in order to clarify the molec-
ular mechanisms underlying FGF-FGFR system
expression during umbilical cord development.
Besides low number of myofibroblasts, Wharton's
jelly produces and accumulates significant amounts of
different growth factors (FGF-2, EGF, TGF-β, PDGF,
IGF-I) in comparison with the umbilical arteries. Con-
centration among the mentioned structures of the
umbilical cord was not different for FGF-1 [21]. The
high amounts of growth factors may strongly stimulate
cells of Wharton's jelly to biosynthesize collagen,
hyaluronate and sulphated proteoglycans [32-34]. Pre-
vious study of Sobolewski and coworkers [4] showed
that Wharton's jelly contains about four times more
collagen and twice as much glycosaminoglycan com-
Fig. 3. Immunohistochemical localization of FGF-1 (a-h) and FGF-2 (i-p) in structures of the porcine umbilical cord (UC) on days 40 (a-
d/i-l) and 114 of pregnancy (e-h/m-p). Positive staining for FGF-1 as well as FGF-2 was observed in the endothelium (arrows) and mus-
cular layer (asterisks) of the UC vein (a, e, i, m) and artery (b, f, j, n), in the amniotic epithelium (arrowheads; c, g, k, o), allantoic duct
(triangle frames; d, h, l, p) and myofibroblasts of Wharton's jelly (circles; c, g, k, o).
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pared to the umbilical cord artery wall. The major role
of FGF-1 as well as FGF-2 in umbilical cord could be
the stimulation of myofibroblasts and smooth muscle
cells to produce extracellular matrix components [33].
Increases in concentration of extracellular matrix com-
ponents of Wharton's jelly might influence mechanical
properties of the UC (resistance to blood flow, elastic-
ity, degree of hydration) that prevent occlusion and
rupture of umbilical vessels [21,35].
The umbilical vessels are major structures of UC
affecting fetus growth. The hemodynamic changes in
feto-placental circulation during pregnancy require
structural adaptation of the umbilical vessels [36, 37].
Expression of FGF (FGF-1 and FGF-2) and FGFR-
1/FGFR-1IIIc in umbilical vessels is probably associat-
ed with structural and functional regulation of endothe-
lial and smooth muscle cells. Earlier studies have
proven that mostly FGF-1/-2, through activation FGFR-
1, induces proliferation of the endothelial cell and
migration in different type of vessels [38,39]. In addi-
tion, FGF-1 and FGF-2 represent effective mitogens for
smooth muscle cells. Growth of vessels wall is mainly
controlled by TGF-β and PDGF [40]. However, Millette
and coworkers [41] presented a novel mechanism by
which PDGF-BB induces the release of FGF-2 and acti-
vation of FGFR-1 followed by the sustained activation
of ERK and proliferation of human smooth muscle
cells. Moreover, action of FGF-1 and FGF-2 in regula-
tion of the umbilical vessels growth can be also related
with the stimulation of endothelial cells for the produc-
tion of different types of metalloproteinases (MMP-1,
MMP-3), which are involved in the breakdown of extra-
cellular matrix during tissue remodeling [42,43].
According to Murakami and coworkers [44], FGFs sig-
naling plays a key role in the maintenance of vascular
integrity. Contrary to VEGF-VEGFR system, the inhi-
bition of FGF-FGFR system activity leads to dissocia-
tion of the VE-cadherin/p120-catenin complex and dis-
Fig. 4. Immunohistochemical localization of FGFR-1 (a-h) and FGFR-2 (i-p) in structures of the porcine umbilical cord (UC) on days 40
(a-d/i-l) and 114 of pregnancy (e-h/m-p). Positive staining for FGFR-1 as well as FGFR-2 was observed in the endothelium (arrows) and
muscular layer (asterisks) of the UC vein (a e i, m) and artery (b, f, j, n), in the amniotic epithelium (arrowheads; c, g, k, o), allantoic duct
(triangle frames; d, h, l, p) and myofibroblasts of Wharton's jelly (circles; c, g, k, o).
assembly of adherens tight junctions. Increase in the
VE-cadherin/p120-catenin binding, through FGF-1 and
FGF-2 – FGFR signaling, induces the decrease in ves-
sels permeability [44,45].
Strong immunoreactivity especially for FGF-1
and FGFR-2, observed in the amniotic epithelium
and allantoic duct, as well as expression of FGFR-
2IIIb mRNA transcript suggests their role in structur-
al reorganization and function of these structures of
UC. Similar to its role in regulation of vascular
integrity, the FGF-1-FGFR-2IIIb system might be a
key player for maintenance of epithelial cell mor-
phology and permeability. The amniotic epithelium
and allantoic duct epithelium of umbilical cord dur-
ing the pig pregnancy is transformed from a single
layer (epithelium simplex cuboideum) at the begin-
ning to a multilayered structure (stratified squamous
epithelium and multilayer epithelium with superficial
cells, respectively) at term [1]. FGF-1, similar to the
FGF-7 (keratinocyte growth factor) may be a potent
regulator, which modulates the proliferation, differ-
entiation and stratification of umbilical cord epitheli-
ums by FGFR-2IIIb [46]. In turn, the effect of FGF-
FGFR system on UC epithelium permeability, similar
to the endothelial barrier, appears to participate in
regulation of adherence junction formation deter-
mined by interactions between epithelial-type of cad-
herin (E-cadherin), p120-catenin and β-catenin
[47,48].
Cell shape, orientation and alignment, as well as
cytoskeleton reorganization, in vivo and in vitro, can
be regulated by blood flow, blood pressure and fetus
movements which affect the UC tension [49]. Even
though the molecular signaling of mechano-transduc-
tion is not clearly understood, it is known that
endothelial and smooth muscle cells undergoing
long-term stretching produce not only different
growth factors (TGF-β, PDGF, FGF) but also struc-
tural and functional proteins, such as collagen, elastin
and integrins [50].
In conclusion, our results demonstrate that both
FGF-1 and FGF-2 as well as FGFR-1 and FGFR-2 are
biosynthesized by UC structures. Furthermore, FGF-1-
FGFR-2 system supported by FGF-2 may be an impor-
tant stimulator and/or regulator of UC formation. On
account of discrepancy between mRNA and protein
abundance additional studies will be needed, however,
to clarify the molecular mechanisms underlying FGF-
FGFR system expression during UC development.
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